Chris Lai is the founder of METiS Pharmaceuticals. METiS Pharmaceuticals has raised $86M in total funding. Latest round: Series A. Based in Beijing, China.
Chris Lai is the CEO and co-founder of METiS Pharmaceuticals, an AI-driven small-molecule and RNA therapeutics company. The company focuses on artificial intelligence-driven formulation and drug delivery. METiS Pharmaceuticals raised $86 million in Series A funding to advance its lead candidate into clinical trials and expand into gene therapy. Prior to METiS, Lai co-founded AquaFresco, an AI-driven water-tech startup.
Full founder directory · Investor directory · Company funding database · Fundraising library